THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES
THIS IS THE INCORPORATED SUCCESSOR CHARITY TO CHARITY NUMBER 287034, WHICH IS ITS UNINCORPORATED PREDECESSOR.The MPS Society is the only registered UK charity providing professional support to individuals, families and professionals affected by MPS and related diseases throughout the UK.
Objects
1. THE RELIEF OF PERSONS SUFFERING FROM MUCOPOLYSACCHARIDE AND RELATED LYSOSOMAL DISEASES; AND2. TO ADVANCE MEDICAL RESEARCH INTO THE CAUSE, CURE, PREVENTION OR RELIEF OF SUCH DISEASES AND RELATED PAEDIATRIC NEURODEGENERATIVE BRAIN DISEASES PROVIDED THAT THE USEFUL RESULTS OF THE RESEARCH SHALL BE PUBLISHED.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a surplus of £59,648 for the year ended 31 December 2025, with total group income of £2,184,220 against total expenditure of £2,152,485. Per the trustees' report, free reserves amounted to £740,781, which exceeds the stated policy target of six months of unrestricted resources.
What the accounts disclose
“the trustees agreed to the established policy whereby the unrestricted funds not committed or invested in tangible fixed assets (‘the free reserves’) held by the charity should be six months of the unrestricted resources.” — page 12
“MPS Commercial Limited (trading as Rare Disease Research Partners) is a wholly owned trading subsidiary of the MPS Society.” — page 12
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 5
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 5
- Employees paid over £60,000: 1 (£90,001–£100,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2023
- Employees paid over £60,000: 3 (£60,001–£70,000: 1; £100,001–£110,000: 2)
- Has a trading subsidiary
Corporate structure
- Registered company of the charity Companies House 07726882
- Trading subsidiary: MPS COMMERCIAL LIMITED Companies House 08621283 · Financial health read from its filings
- Trading subsidiary: RARE DISEASE RESEARCH PARTNERS LTD Companies House 12249341
- Profit before tax: £157k
- Donated/gift-aided to the charity: £157k
- Interest charged on intercompany loan: £6,375. Intercompany loan balance owed to parent: £256,680.
“The company distributes all of its profits to its parent undertaking, The Society For Mucopolysaccharide Diseases under Gift Aid. The payment for 2025 was £156,680”
- Donated/gift-aided to the charity: £1
- Amounts owed by group undertakings were £1,000 in 2025 and £4,000 in 2024.
“Amounts owed by group undertakings 1 4”
Leadership, per the charity’s website
- Bob Stevens — Group CEO
Funders the charity credits
- National Lottery Community Fund
- Project Alive
- the Sylvia Aitken Charitable Trust
- David Lister Charitable Trust
- the Blair Foundation
- Himat Tanna Charitable Trust
- the Florence Turner Trust
- the Boshier-Hinton Foundation
- The Arnold Clark Community Fund
- The Reed Foundation
- Bruce Wake Charitable Trust
- Christopher and Elspeth Thomas Charitable Trust
- the Charles and Elsie Sykes Trust
- Baddiley Consolidated Charities
- The Eveson Trust
Company officers (Companies House)
- MCKEE, Glenn, Dr on trustee list
- HEALES, Simon James Robert, Professor on trustee list
- HUGHES, Derralynn Arlene, Professor on trustee list
- BROWN, Katy Joanne on trustee list
- STEWART, Fiona Jane, Dr on trustee list
- PEARSON, Philip John on trustee list
- PATTON, David Maurice on trustee list
- WINCHESTER, Bryan Gordon, Prof on trustee list
- ROBINS, Wilma on trustee list
- ELLERTON, Toni Anne
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/12/2025)
Register events
- Received assets from another charity (24/01/2012)
Trustees
- DAVID MAURICE PATTON
- Dr FIONA JANE STEWART
- Dr GLENN McKee
- JUDITH EVANS
- Katy Joanne Brown
- PROFESSOR BRYAN WINCHESTER
- PROFESSOR DERRALYNN ARLENE HUGHES
- PROFESSOR SIMON JAMES ROBERT HEALES
- Philip John Pearson
- WILMA ROBINS
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £2.2m | £2.2m |
| 31/12/2024 | £1.9m | £1.9m |
| 31/12/2023 | £1.8m | £2.0m |
| 31/12/2022 | £1.7m | £2.0m |
| 31/12/2021 | £1.4m | £1.6m |
Common questions
Is THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a surplus of £59,648 for the year ended 31 December 2025, with total group income of £2,184,220 against total expenditure of £2,152,485. Per the trustees' report, free reserves amounted to £740,781, which exceeds the stated policy target of six months of unrestricted resources. Its FY2025 accounts were audited by Xeinadin Audit Limited.
Who funds THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES?
Funders whose own accounts filings name THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES as a grant recipient include THE JOHN COATES CHARITABLE TRUST, THE CLOVER TRUST, DAVID LISTER CHARITABLE TRUST, PILKINGTON CHARITIES FUND, SANDRA CHARITABLE TRUST.
Known funders
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| The National Lottery Community Fund | 25/07/2024 | £20k | Mental health support for people with MPS; Fabry and related diseases |
| The National Lottery Community Fund | 20/12/2023 | £418k | Rare But Not Alone |
| The National Lottery Community Fund | 13/05/2022 | £10k | Counselling for young people diagnosed with an MPS or related disease |
| The National Lottery Community Fund | 03/03/2021 | £195k | Rare but not alone- Connecting the MPS Community |
| The National Lottery Community Fund | 11/05/2020 | £38k | Advocacy and support- Covid 19 response |
| The National Lottery Community Fund | 26/10/2017 | £636 | Society for Mucopolysaccharide Diseases |
| City Bridge Foundation | 06/06/2013 | £77k | Grant to Society for Mucopolysaccharide Diseases |
| The National Lottery Community Fund | 22/11/2005 | £4k | Training for volunteers |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE BARBOUR FOUNDATION | 3 | £77k |
| THE CLARE MILNE TRUST | 3 | £12k |
| THE ALBERT GUBAY CHARITABLE FOUNDATION | 2 | £793k |
| MOONDANCE FOUNDATION | 2 | £779k |
| THE THREE OAKS TRUST | 2 | £58k |
| THE SIR JAMES RECKITT CHARITY | 2 | £32k |
| THE LAWSON TRUST CIO | 2 | £27k |
| THE HULL AND EAST RIDING CHARITABLE TRUST | 2 | £16k |
Charities like this
- MULTIPLE SCLEROSIS SOCIETY
- MULTIPLE SCLEROSIS TRUST
- MS COMMUNITY ACTION & SUPPORT
- MULTIPLE SCLEROSIS INTERNATIONAL FEDERATION
- SUFFOLK MULTIPLE SCLEROSIS THERAPY CENTRE
- PSS (UK)
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE SOCIETY FOR MUCOPOLYSACCHARIDE DISEASES | £2.2m | — | — | above | — | no doubt |
| MULTIPLE SCLEROSIS SOCIETY | £30.7m | — | — | below | — | no doubt |
| MULTIPLE SCLEROSIS TRUST | £3.1m | — | — | above | — | no doubt |
| MS COMMUNITY ACTION & SUPPORT | £14k | — | 0 | below | — | no doubt |
| MULTIPLE SCLEROSIS INTERNATIONAL FEDERATION | £1.5m | £110,000 - £119,999 | — | unclear | — | no doubt |
| SUFFOLK MULTIPLE SCLEROSIS THERAPY CENTRE | £252k | — | 0 | above | — | no doubt |